首页> 外国专利> A HUMANIZED ANTIBODY BEING ASSOCIATED WITH BETA-AMYLOID PEPTIDE ((A?- POLYNUCLEIC ACID CODING IT, A PHARMACEUTICAL COMPOSITION CONTAINING IT, AND USE OF SAID HUMANIZED ANTIBODY FOR MAKING MEDICINAL AGENT FOR PROPHYLAXIS AND TREATMENT OF STATES ASSOCIATED WITH FORMATION OF BETA-AMYLOID PLAQUES

A HUMANIZED ANTIBODY BEING ASSOCIATED WITH BETA-AMYLOID PEPTIDE ((A?- POLYNUCLEIC ACID CODING IT, A PHARMACEUTICAL COMPOSITION CONTAINING IT, AND USE OF SAID HUMANIZED ANTIBODY FOR MAKING MEDICINAL AGENT FOR PROPHYLAXIS AND TREATMENT OF STATES ASSOCIATED WITH FORMATION OF BETA-AMYLOID PLAQUES

机译:与β-淀粉样肽((?

摘要

The invention relates to humanized antibodies being associated with beta-amyloid peptide (A?), and polynucleic acids coding them. Also disclosed is a pharmaceutical composition containing said antibodies, and use of said humanized antibodies for making medicinal agent for prophylaxis and treatment of states associated to formation of beta amyloid plaques, in particular for the treatment of clinical or preclinical Alzheimer's disease, DownÆs syndrome, clinical or preclinical form of cerebral amyloid angiopathy or for the treatment, prevention or reversing deterioration of perceptive activity insaid diseases.
机译:本发明涉及与β-淀粉样肽(Aβ)有关的人源化抗体,以及编码它们的多核酸。还公开了包含所述抗体的药物组合物,以及所述人源化抗体在制备药物中的用途,所述药物用于预防和治疗与β淀粉样蛋白斑形成有关的状态,特别是用于临床或临床前阿尔茨海默氏病,唐氏综合症,临床或临床前形式的脑淀粉样血管病,或用于治疗,预防或逆转所述疾病的知觉活性的下降。

著录项

  • 公开/公告号UA75881C2

    专利类型

  • 公开/公告日2002-10-15

    原文格式PDF

  • 申请/专利权人 WASHINGTON UNIVERSITY;ELI LILLY AND COMPANY;

    申请/专利号UA20020086888

  • 发明设计人

    申请日2001-02-26

  • 分类号A61K39/395;C12N15/09;A61K;A61K39;A61K39;A61P;A61P25/28;C07K;C07K16/18;C12N;C12N5;C12N5/10;C12N15/13;C12R1/91;

  • 国家 UA

  • 入库时间 2022-08-22 00:43:28

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号